Post-approval studies (Phase 4)UnknownNCT01893229What this trial is testingComparative Efficacy and Acceptability of Antimanic Drugs in Acute ManiaWho this might be right forBipolar Disorder Guiyun Xu 120
Large-scale testing (Phase 3)Study completedNCT00129220What this trial is testingTrial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderWho this might be right forBipolar Disorder Eli Lilly and Company 224
Post-approval studies (Phase 4)Study completedNCT00190892What this trial is testingOlanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaWho this might be right forBipolar Disorder Eli Lilly and Company 120
Large-scale testing (Phase 3)Study completedNCT00037674What this trial is testingA Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 434
Post-approval studies (Phase 4)Study completedNCT00277212What this trial is testingA Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed EpisodeWho this might be right forBipolar Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 1,169
Large-scale testing (Phase 3)Study completedNCT00259272What this trial is testingValidation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With OlanzapineWho this might be right forBipolar Disorder I or II Eli Lilly and Company 141
Large-scale testing (Phase 3)Study completedNCT00035230What this trial is testingA Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338
Large-scale testing (Phase 3)Study completedNCT00265330What this trial is testingSafety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)Who this might be right forBipolar Disorder Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 169
Large-scale testing (Phase 3)Study completedNCT03259555What this trial is testingA Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I DisorderWho this might be right forBipolar I DisorderManic Episode Otsuka Pharmaceutical Development & Commercialization, Inc. 322
Large-scale testing (Phase 3)Study completedNCT00280566What this trial is testingSafety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)Who this might be right forBipolar ManiaBipolar Disorder Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 584
Testing effectiveness (Phase 2)Active Not RecruitingNCT07046494What this trial is testingStudy Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderWho this might be right forBipolar 1 Disorder Rapport Therapeutics Inc. 253
Large-scale testing (Phase 3)Looking for participantsNCT07140913What this trial is testingEvaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotrigineWho this might be right forManiaBipolar Disorder Bristol-Myers Squibb 424
Large-scale testing (Phase 3)WithdrawnNCT01124877What this trial is testingSafety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)Who this might be right forBipolar Disorder Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Testing effectiveness (Phase 2)Study completedNCT00650611What this trial is testingThe Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersWho this might be right forSchizophreniaBipolar DisorderSchizoaffective Disorder Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 63
Large-scale testing (Phase 3)Study completedNCT00240721What this trial is testingThe Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderWho this might be right forBipolar DisordersMood DisordersAffective Disorders, Psychotic Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Large-scale testing (Phase 3)Study completedNCT04819776What this trial is testingEvaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderWho this might be right forBipolar I Disorder Vanda Pharmaceuticals 417
Large-scale testing (Phase 3)Looking for participantsNCT06951711What this trial is testingEvaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)Who this might be right forBipolar Disorder Type I With Mania or Mania With Mixed Features Bristol-Myers Squibb 274
Large-scale testing (Phase 3)Study completedNCT00081380What this trial is testingEfficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderWho this might be right forBipolar Disorder AstraZeneca 710
Large-scale testing (Phase 3)Study completedNCT00764478What this trial is testingFixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)Who this might be right forBipolar 1 Disorder Organon and Co 367
Large-scale testing (Phase 3)Study completedNCT01244815What this trial is testingEfficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)Who this might be right forBipolar Disorder, Pediatric Organon and Co 404